​

Amgen (AMGN) Stock Forecast, Price Target & Predictions

OverviewRevenueOwnershipFinancialsChartTranscripts

AMGN Stock Forecast

Amgen (AMGN) stock forecast, based on 36 Wall Street analysts, predicts a 12-month average price target of $368.50, with a high of $425.00 and a low of $315.00. This represents a 16.10% increase from the last price of $317.39.

$250 $290 $330 $370 $410 $450 High: $425 Avg: $368.5 Low: $315 Last Closed Price: $317.39

AMGN Stock Rating

Amgen stock's rating consensus is Buy, based on 36 Wall Street analysts. The breakdown includes 0 Strong Buy (0.00%), 21 Buy (58.33%), 12 Hold (33.33%), 3 Sell (8.33%), and 0 Strong Sell (0.00%).

Buy
Total 36 0 3 12 21 Strong Sell Sell Hold Buy Strong Buy

AMGN Price Target Upside V Benchmarks

TypeNameUpside
StockAmgen16.10%
SectorHealthcare Stocks 15.45%
IndustryDrug Manufacturers - General Stocks7.11%

Price Target Trends

1M3M12M
# Anlaysts5711
Avg Price Target$379.20$358.71$342.45
Last Closing Price$317.39$317.39$317.39
Upside/Downside19.47%13.02%7.90%
Ratings Trends
DateStrong BuyBuyHoldSellStrong SellTotal
Dec, 25410152132
Nov, 25310152131
Oct, 25310152131
Sep, 25310152131
Aug, 25212152132
Analyst Price Target Forecasts
DateAnalystCompanyPrice TargetPrice when PublishedPrice Target/Price when PublishedPrice Target/Last Closing Price
Dec 10, 2025HSBC$425.00$313.8535.42%33.90%
Dec 03, 2025Evan SeigermanBMO Capital$372.00$338.369.94%17.21%
Nov 25, 2025Wells Fargo$400.00$334.3019.65%26.03%
Nov 24, 2025Truist Financial$318.00$336.20-5.41%0.19%
Nov 14, 2025David AmsellemPiper Sandler$381.00$332.4314.61%20.04%
Nov 06, 2025Cantor Fitzgerald$315.00$318.40-1.07%-0.75%
Nov 05, 2025Wells Fargo$300.00$296.701.11%-5.48%
Aug 25, 2025Piper Sandler$342.00$288.4718.56%7.75%
May 02, 2025Trung HuynhUBS$315.00$281.2212.01%-0.75%
Apr 22, 2025Cantor Fitzgerald$305.00$278.409.55%-3.90%
Analyst Rating Forecasts
DateCompanyPrevious RatingNew RatingRating Change
Dec 10, 2025HSBCBuyBuyhold
Dec 03, 2025BMO CapitalOutperformOutperformhold
Nov 25, 2025Goldman SachsBuyBuyhold
Nov 06, 2025Cantor FitzgeraldNeutralNeutralhold
Nov 05, 2025Piper SandlerOverweightOverweighthold
Aug 25, 2025Piper SandlerOverweightOverweighthold
May 02, 2025Morgan StanleyEqual-WeightEqual-Weighthold
Apr 22, 2025Cantor FitzgeraldOverweightNeutraldowngrade
Feb 12, 2025Piper SandlerOverweightOverweighthold
Feb 05, 2025CitigroupNeutralNeutralhold

Financial Forecast

EPS Forecast

$5 $11 $17 $23 $29 $35 Dec 20 Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 20Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$12.40$10.34$12.18$12.56$7.56----
Avg Forecast$16.08$16.82$17.68$18.56$19.59$21.01$21.45$22.22$22.74
High Forecast$16.75$17.52$18.41$18.98$19.86$22.39$30.68$31.07$23.91
Low Forecast$15.47$16.19$16.80$18.23$19.25$19.62$10.68$16.86$21.04
Surprise %-22.89%-38.53%-31.11%-32.33%-61.41%----

Revenue Forecast

$20B $24B $28B $32B $36B $40B Dec 20 Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 20Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$25.42B$25.98B$26.32B$28.19B$33.42B----
Avg Forecast$25.36B$26.00B$26.17B$28.12B$33.20B$34.61B$35.07B$35.60B$36.33B
High Forecast$26.18B$26.84B$27.00B$28.29B$33.48B$35.96B$35.08B$35.66B$37.75B
Low Forecast$24.63B$25.25B$25.17B$27.97B$32.91B$32.45B$35.06B$35.55B$34.23B
Surprise %0.24%-0.09%0.58%0.26%0.68%----

Net Income Forecast

$0 $4B $8B $12B $16B $20B Dec 20 Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 20Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$7.26B$5.89B$6.55B$6.72B$4.09B----
Avg Forecast$6.37B$5.71B$6.49B$6.72B$10.52B$11.30B$7.13B$12.89B$12.24B
High Forecast$7.64B$6.85B$7.79B$8.06B$10.68B$12.05B$16.50B$16.71B$12.86B
Low Forecast$5.10B$4.56B$5.19B$5.37B$10.36B$10.56B$5.74B$9.07B$11.32B
Surprise %14.03%3.29%0.90%--61.12%----

AMGN Forecast FAQ

Is Amgen stock a buy?

Amgen stock has a consensus rating of Buy, based on 36 Wall Street analysts. The rating breakdown includes 0 Strong Buy, 21 Buy, 12 Hold, 3 Sell, and 0 Strong Sell, reflecting a consensus that Amgen is a favorable investment for most analysts.

What is Amgen's price target?

Amgen's price target, set by 36 Wall Street analysts, averages $368.5 over the next 12 months. The price target range spans from $315 at the low end to $425 at the high end, suggesting a potential 16.10% change from the previous closing price of $317.39.

How does Amgen stock forecast compare to its benchmarks?

Amgen's stock forecast shows a 16.10% upside, outperforming the average forecast for the healthcare stocks sector (15.45%) and outperforming the drug manufacturers - general stocks industry (7.11%).

What is the breakdown of analyst ratings for Amgen over the past three months?

  • December 2025: 12.50% Strong Buy, 31.25% Buy, 46.88% Hold, 6.25% Sell, 3.12% Strong Sell.
  • November 2025: 9.68% Strong Buy, 32.26% Buy, 48.39% Hold, 6.45% Sell, 3.23% Strong Sell.
  • October 2025: 9.68% Strong Buy, 32.26% Buy, 48.39% Hold, 6.45% Sell, 3.23% Strong Sell.

What is Amgen’s EPS forecast?

Amgen's average annual EPS forecast for its fiscal year ending in December 2025 is $21.01, marking a 177.91% increase from the reported $7.56 in 2024. Estimates for the following years are $21.45 in 2026, $22.22 in 2027, and $22.74 in 2028.

What is Amgen’s revenue forecast?

Amgen's average annual revenue forecast for its fiscal year ending in December 2025 is $34.61B, reflecting a 3.55% increase from the reported $33.42B in 2024. The forecast for 2026 is $35.07B, followed by $35.6B for 2027, and $36.33B for 2028.

What is Amgen’s net income forecast?

Amgen's net income forecast for the fiscal year ending in December 2025 stands at $11.3B, representing an 176.33% increase from the reported $4.09B in 2024. Projections indicate $7.13B in 2026, $12.89B in 2027, and $12.24B in 2028.